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The value of parasternal mediastinoscopy in staging bronchial carcinoma
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Abstract. Computed tomography (CT) is the non-invasive staging procedure of choice for assessment of metas­
tasis to mediastinal lymph nodes in patients with bronchial carcinoma. Cervical mediastinoscopy can provide his­
tologic evidence of mediastinal spread to the peritracheal, tracheobronchial and subcarinal lymph nodes. Sub- 
aortic and para-aortic nodes cannot be sampled via this route. The present study was performed to assess the 
staging value of the parasternal mediastinoscopy as a separate entity. Cervical and parasternal mediastinoscopy 
was performed in 37 patients with a proven diagnosis of non-small cell carcinoma of the left upper lobe. In 16 pa­
tients lymph node or tumor tissue could be biopsied via the parasternal route, in 21 patients no parasternal bi­
opsy was taken. Of the 16 cases with biopsies, only one was positive (6%). Histologic examination of lymph node 
biopsy tissue was false negative in one other patient (6%). Of the 21 patients without biopsies taken during par­
asternal mediastinoscopy, three (14%) had proven lymphogenic spread to the subaortic and para-aortic nodes, 
detected at thoracotomy. The parasternal procedure changed treatment in only one patient (3%). Diagnostic sen­
sitivity was 20%. It is concluded that parasternal mediastinoscopy should not be used as a routine staging proce­
dure in patients with left upper lobe lung cancer. [Eur J Cardio-thorac Surg (1995) 9: 655-658]
Key words: Parasternal -  Mediastinoscopy -  Lung cancer
The value of mediastinoscopy in the preoperative assess- 
ment of bronchial carcinoma is a subject of ongoing dis­
cussion. Cervical mediastinoscopy should be used for stag­
ing in the case of a so-called positive computed tomogra­
phy (CT) scan (mediastinal lymph nodes of 1.5 cm diam­
eter or larger, or a group of nodes each 1.0 cm or larger)
[4J. Histologic evidence of mediastinal metastasis is man­
datory in all cases of enlarged nodes on CT scan.
The value of parasternal (anterior) mediastinoscopy or 
mediastinotomy has been discussed in only a few recent 
publications [1, 4, 5, 8, 11, 14]. In many instances no dif­
ference is made between the staging value of the cervical 
and the parasternal procedure. Due to the route of lympho­
genic spread, the parasternal mediastinoscopy is supposed 
to be important in the preoperative assessment of left upper
lobe tumors [3, 10, 15]. The benefit of cervical mediasti­
noscopy is limited to patients with central mediastinal in­
volvement. Parasternal mediastinotomy is an alternative 
procedure, but is apparently more invasive than mediasti­
noscopy. The extended cervical mediastinoscopy, as ad­
vocated by Ginsberg, is not practised by many surgeons 
[1]. In some institutes the attitude towards mediastinos­
copy in general, and towards parasternal mediastinoscopy 
in particular, appears to have changed. This is partly due 
to the development of improved CT imaging techniques, 
which show mediastinal structures with a higher defini­
tion than 5 or 10 years ago,
In order to reassess the value of the staging of lympho­
genic spread of bronchial carcinoma by parasternal med­
iastinoscopy, the results of a 3-year period are described.
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Materials and methods
A retrospective study was performed, analyzing the results of all pa­
tients who had undergone a parasternal mediastinoscopy as a preop- 
erative staging procedure in bronchial carcinoma in the 3-year peri­
od 1990-1992. In this period all patients with proven non-small cell 
lung cancer (NSCLC) of the left upper lobe (above stage T l - and in
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all cases of adenocarcinoma), and without signs of metastatic dis­
ease or local non-resectability, underwent a cervical and a paraster­
nal mediastinoscopy; the patient’s general condition had to permit a 
thoracotomy and resection if the results were found to be negative.
During the procedure of mediastinoscopy the cervical route was 
always employed first. The parasternal or anterior mediastinoscopy 
was performed before closure of the cervical wound so that bi-dig­
ital palpation was possible. A small left parasternal incision through 
the second intercostal space, without resection of costal cartilage, 
was used to allow a palpating finger and a mediastinoscope. Biop­
sies were only taken in the case of visible or palpable lymph nodes 
or tumor. The clinical data of 37 patients were investigated, togeth­
er with the results from X-ray studies, mediastinoscopy and thora­
cotomy reports and histologic findings.
Results
Fig. 1. Schematic drawing of 
left lateral view of the medias 
tinum with subaortic (5) and 
para-aortic (6) lymph nodes. 
Numbers according to Ameri­
can Joint Committee on Can­
cer, classification of regional 
lymph nodes
The group consisted of 34 men and 3 women. The mean 
age was 64.3 years. All patients had a proven left upper 
lobe bronchial carcinoma. Twenty-eight tumors were 
squamous cell carcinomas, six were adenocarcinomas and 
three were non-small cell undifferentiated carcinomas. Ta­
ble 1 depicts pathological tumor stages as assessed retro­
spectively for all patients. Table 2 shows N-stages after 
CT scan and cervical plus parasternal mediastinoscopy 
versus N-stages after thoracotomy with definitive histo­
logic investigation. In three patients the CT scan results 
were not available for our study. In only 16 cases of 37 
(43%) parasternal mediastinoscopies was a biopsy of a 
lymph node or supposed tumor tissue taken. In the remain­
ing 21 patients no lymph node or tumor was seen or pal­
pated. Five patients had histologically proven tumor me- 
tastases in the subaortic or para-aortic lymph nodes (Fig. 1, 
Stations 5 and 6) according to definitive staging after thor­
acotomy. Of the 16 patients who underwent a prethoracot­
omy parasternal biopsy only one had a histologically 
proven adenocarcinoma in the specimen, the cervical med­
iastinoscopy was negative. One patient had a false nega­
tive parasternal biopsy result. Of the 21 patients who 
underwent parasternal mediastinoscopy without biopsy 
three had false negative results according to definitive
1 positive
16 biopsied
15 negative
1 sub/para-aort. 
nodes +
thoracotomy
14 sub/para-aort. 
nodes -
37 patients parasternal mediastinoscopy
3 sub/para-aort. 
nodes +
thoracotomy
18 sub/para-aort. 
nodes -
Fig. 2. Flow diagram showing the numbers of procedures and the 
histologic results
Table 1. pTN stages in 37 patients. Definitive tumor stages. Pa­
tients with distant métastasés (Mj) are not presented in this study
S tage I : 16 patients (T1 NO 2, T2N0 14)
Stage II : 6 patients (T2N1 6)
Stage Ilia : 12 patients (T2N2 7, T3NÛ 1, T3N1 1, T3N2 3) 
Stage Illb ; 3 patients (T4N0 1, T4N2 2)
Table 2. N-stages after CT and cervical plus parasternal mediasti­
noscopy versus definitive N-stages. Comparison of clinical lymph 
node staging with staging after thoracotomy showed understaging 
of the former. N2 disease in this table concerns metastatic spread to 
sub- or para-aortic nodes and/or to other N2 lymph node stations
CT + mediastinoscopy Definitive
NO or N1 29 25
N2 5 12
no CT available 3
staging at thoracotomy with sub- and para-aortic lymph 
nodes positive (Fig. 2, flow diagram).
The sensitivity of the parasternal mediastinoscopy was 
20%: of the five patients with métastasés to sub- and para­
aortic lymph nodes, only one was detected before thora­
cotomy. The patient with positive parasternal biopsy re­
sult did not undergo resection, but in no other patient was 
treatment influenced by parasternal mediastinoscopy. The 
negative predictive value was 89%.
In ten cases (27%) the pleural cavity was inadvertently 
opened and three were treated with short-term drainage. 
The combined procedure had a mean duration of 63 min 
(range 45-90) compared to 43 min (range 30-60) for the 
cervical mediastinoscopy alone, as performed in our insti­
tution in patients with a bronchial carcinoma not located 
in the left upper lobe.
Computer tomography scan imaging of the sub- and 
para-aortic area in these 37 patients proved to be false neg-
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ative in two patients (sensitivity 60%; five patients had 
lymphatic metastasis to sub- and para-aortic nodes). In 
four cases enlarged sub- and para-aortic lymph nodes on 
CT scan were found to be negative at histologic examina­
tion of biopsy specimens during thoracotomy. Parasternal 
mediastinoscopy had been negative in these patients. A c­
cording to CT scan the sub- and para-aortic lymph nodes 
were true positive in 2 patients and true negative in 26 pa­
tients; in three patients CT scan was not available.
Conventional staging
Discussion
From the results of this study it appears that the paraster­
nal mediastinoscopy does not add valuable information to 
preoperative staging in most cases. A negative predictive 
value of 89% and a sensitivity of 20% are too low to ju s­
tify the parasternal mediastinoscopy as a routine proce­
dure in patients with a left upper lobe or left main bron­
chus carcinoma. The added parasternal procedure changed 
treatment in only one patient (3%). It may even be argued 
that patients with subaortic or para-aortic lymph node me­
tastasis without any further mediastinal dissemination will 
benefit from complete surgical resection [12, 18].
The high false negative rate could be explained by the 
fact that the procedure is not very easy to perform, due to 
lack of a clearly visible point of anatomic reference, such 
as the trachea in cervical mediastinoscopy. Too often no 
lymph nodes were found and not even a biopsy was taken. 
Sometimes, fatty tissue prohibited a clear view on any 
lymph nodes in the dangerous sub- and para-aortic area. 
Higher biopsy ratios can probably only be reached in 
highly specialized units, resulting in prolonged proce­
dures. In most institutes other staging procedures will be 
beneficial, for instance a parasternal mediastinotomy. A 
higher morbidity may be associated with this technique, 
although Vallieres et al. described the use of parasternal 
mediastinotomy on an ambulatory basis [17]. If an aggres­
sive surgical approach towards isolated sub- and para-aor- 
tic metastasis is adopted, a parasternal mediastinoscopy 
can be omitted, whereas in doubtful cases a parasternal 
mediastinotomy is to be preferred to this procedure. The 
use of extended cervical mediastinoscopy is limited by the 
same difficult anatomic orientation as the parasternal med­
iastinoscopy [1]. The authors have no personal experience 
with the extended cervical procedure.
In our series CT scan, usually performed without the 
use of intravenous contrast, could not clearly differentiate 
between NO or N1 and N2 disease. The reported sensitiv­
ity of mediastinal lymph node staging by CT scan is ap­
proximately 60-80% [4, 9,13, 19]. It is to be expected that 
modern CT scanning techniques, with the addition of intra­
venous contrast studies, will indicate whether a patient 
could benefit from a cervical mediastinoscopy or a para­
sternal procedure [7,16]. The overall accuracy of CT scan­
ning in preoperative staging of the entire mediastinum was
not studied here.
Video-assisted thoracoscopy, a rapidly developing min­
imally invasive surgical technique, could be useful in stag­
ing the mediastinum, especially the sub- and para-aortic 
lymph nodes [2, 6]. It offers a better view of the medias-
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Fig. 3. Proposed decision tree for mediastinal staging in resectable 
left upper lobe lung cancer
tinum and could thus be a more complete staging proce­
dure than the parasternal (anterior) mediastinoscopy. 
Video-assisted thoracoscopy is probably comparable to 
parasternal mediastinoscopy in its postoperative morbid­
ity and it is less invasive than a parasternal mediastinot­
omy with resection of costal cartilage, Its accuracy in lung 
cancer staging has still to be settled.
The results of this study indicate that histologic stag­
ing in left upper lobe lung cancer should not be done by 
parasternal mediastinoscopy. In cases with central medi­
astinal nodes on CT scan, a cervical mediastinoscopy is 
the procedure of choice. In cases of isolated enlarged sub- 
or para-aortic nodes, a parasternal mediastinotomy or a 
video-assisted thoracoscopy is indicated to obtain histo­
logic evidence, unless a resection with curative intent is 
planned (Fig. 3, decision tree). We therefore conclude that 
the parasternal mediastinoscopy is not valuable as a rou­
tine staging procedure in bronchial carcinoma. Only in 
cases of isolated sub- or para-aortic lymph node involve­
ment according to CT scan, not in combination with cen­
tral mediastinal lymph node involvement, could sampling 
via the parasternal route lead to a change in management.
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